A LM-302 Combined With Toripalimab Phase II Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
A Phase II, Open-Label, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of LM-302 Combined With Toripalimab in CLDN18.2 Positive Patients advanced gastro-Intestinal Cancer
Epistemonikos ID: 5fdf677f4a8f98ce1c28b37dbca2d8b8be1be4fa
First added on: May 15, 2024